Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas, Nell Saunders, Piet Maes, et al.
Nature (2021)
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 872-880.e3
Open Access | Times Cited: 197
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
Science (2022) Vol. 378, Iss. 6620, pp. 619-627
Open Access | Times Cited: 193
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
Takuya Tada, Hao Zhou, Belinda M. Dcosta, et al.
EBioMedicine (2022) Vol. 78, pp. 103944-103944
Open Access | Times Cited: 137
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins
Zijun Wang, Frauke Muecksch, Alice Cho, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 998-1012.e8
Open Access | Times Cited: 128
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
Denisa Bojková, Marek Widera, Sandra Ciesek, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 319-321
Open Access | Times Cited: 118
The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads
Amary Fall, Raghda E. Eldesouki, Jaiprasath Sachithanandham, et al.
EBioMedicine (2022) Vol. 79, pp. 104008-104008
Open Access | Times Cited: 117
Towards SARS-CoV-2 serotypes?
Etienne Simon‐Lorière, Olivier Schwartz
Nature Reviews Microbiology (2022) Vol. 20, Iss. 4, pp. 187-188
Open Access | Times Cited: 102
Omicron, the great escape artist
Alexandra Flemming
Nature reviews. Immunology (2022) Vol. 22, Iss. 2, pp. 75-75
Open Access | Times Cited: 94
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
Seong Jin Choi, Dong-Uk Kim, Ji Yun Noh, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 3, pp. 447-448
Open Access | Times Cited: 94
Three-dose vaccination elicits neutralising antibodies against omicron
Mary Wu, Emma Wall, Edward J Carr, et al.
The Lancet (2022) Vol. 399, Iss. 10326, pp. 715-717
Open Access | Times Cited: 91
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay
Viruses (2022) Vol. 14, Iss. 1, pp. 79-79
Open Access | Times Cited: 76
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 66
Virological characteristics of SARS-CoV-2 BA.2 variant
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 63
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
Giorgio Tiecco, Samuele Storti, Melania Degli Antoni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1987-1987
Open Access | Times Cited: 55
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Nana Zhang, Rongrong Zhang, Yifei Zhang, et al.
Cell Research (2022) Vol. 32, Iss. 4, pp. 401-403
Open Access | Times Cited: 55
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
Franck Touret, Cécile Baronti, Hawa Sophia Bouzidi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 52
Literature Review of Omicron: A Grim Reality Amidst COVID-19
Suraj Arora, Vishakha Grover, Priyanka Saluja, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 451-451
Open Access | Times Cited: 49
In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
Franck Touret, Cécile Baronti, Boris Pastorino, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
Xiaojing Chi, Xinhui Zhang, Shengnan Pan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Recent insights into SARS‐CoV‐2 omicron variant
Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 43
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
John E. Bowen, Kaitlin R. Sprouse, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42
Structural basis of Omicron neutralization by affinity-matured public antibodies
Daniel J. Sheward, Pradeepa Pushparaj, Hrishikesh Das, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top